Methods of targeted genetic alteration in plant cells

Patent metadata

Field	Value
Publication number	US-12215329-B2
Application number	US-201816485806-A
Country	US
Kind code	B2
Filing date	Feb 15, 2018
Priority date	Feb 15, 2017
Publication date	Feb 4, 2025
Grant date	Feb 4, 2025

Abstract

The current invention relates to methods of targeted genetic alteration in cells, preferably plant cells, as well as to plant cells and plants thus obtained using at least a fusion protein comprising a site-specific nuclease domain and a deaminase domain, or a construct encoding the same. The method also provides for a composition and a kit comprising a combination of a first fusion protein comprising a cytosine deaminase domain and a second fusion protein comprising an adenine deaminase domain, preferably for use in the method of the invention. The method provides for targeted alteration of a DNA duplex in plant cells with increased efficacy.

First claim

The invention claimed is:

1. A method for targeted conversion of one or more cytosines to thymines (C-to-T) in combination with one or more adenines to guanines (A-to-G) in a target sequence in a cell, comprising
i) contacting DNA in the cell with at least a first and a second fusion protein,
wherein the first fusion protein comprises a CRISPR-nuclease domain and a cytosine deaminase domain and wherein the second fusion protein comprises a CRISPR-nuclease domain and an adenine deaminase domain,
wherein the DNA is contacted transiently by at least one of:
transiently introducing into the cell one or more DNA constructs for the combined expression of the first and second fusion proteins; and
transiently introducing into the cell the first and second fusion proteins,

wherein the cell is transfected using a transfection medium comprising a guide RNA and both the first and the second fusion protein, or construct(s) encoding the same,
wherein the first and second fusion protein comprise the same CRISPR-nuclease domain; and
ii) sequencing the DNA to identify the C-to-T and A-to-G conversions in the target sequence.

2. The method according to claim 1 , wherein the CRISPR-nuclease domain is Cas9 or Cpf1.

3. The method according to claim 1 , wherein the cytosine deaminase domain of the first fusion protein is selected from the group consisting of an apolipoprotein B mRNA-editing complex (APOBEC) family deaminase, an activation-induced cytosine deaminase (AID), and an ACF1/ASE deaminase, or a variant thereof, and/or wherein the adenine deaminase domain of the second fusion protein is at least one of an ADAT family deaminase, ADAR1, ADAR2 and TadA, or a variant thereof.

4. The method according to claim 1 , wherein the deaminase domain in at least one of the fusion proteins is fused to the N-terminus of the nuclease domain.

5. The method according to claim 1 , wherein the first fusion protein comprising a cytosine deaminase domain further comprises a Uracil DNA glycosylase inhibitor domain.

6. The method according to claim 5 , wherein the Uracil DNA glycosylase inhibitor domain is fused to the C-terminus of the nuclease domain.

7. The method according to claim 1 , wherein the guide RNA is contacted to the DNA by introducing into the cell one or more DNA constructs for expression of said guide RNAs in the cell.

8. The method according to claim 1 , wherein the guide RNA is contacted to said DNA molecule by introducing into the cell said guide RNA.

9. The method according to claim 1 , wherein the cell is a plant cell, and wherein
at least one of the fusion proteins;
the guide RNA; and/or
one or more constructs for expression of at least one of the fusion proteins and/or the guide RNA, are introduced into the plant cell using polyethylene glycol (PEG) mediated transformation.

10. The method according to claim 1 , wherein the cell is a plant cell.

11. A plant, plant part, plant product, seed, or plant cell obtained by the method of claim 1 wherein the cell is a plant cell, wherein the plant, plant part, seed, or plant cell is modified by comprising the targeted alteration when compared to a control plant, plant part, seed, or plant cell.

12. A composition comprising a first fusion protein and second fusion protein as defined in claim 1 , or construct(s) encoding the same, wherein the first fusion protein comprises a cytosine deaminase domain and the second fusion protein comprises an adenine deaminase domain.

13. A kit for targeted nucleotide editing of DNA in a cell comprising at least a first and a second fusion protein as defined in claim 1 , wherein the first fusion protein comprises a cytosine deaminase domain and the second fusion protein comprises an adenine deaminase domain.

14. The method according to claim 9 , wherein the PEG mediated transformation is conducted using an aqueous medium comprising PEG.

15. The method according to claim 10 , further comprising the step of regenerating a plant or descendent thereof comprising the targeted alteration.

16. The plant, plant part, plant product, seed, or plant cell according to claim 11 , wherein the control plant, plant part, seed, or plant cell is a plant, plant part, seed, or plant cell before the targeted alteration was introduced by the method.

17. The method according to claim 1 , wherein the target sequence is at least one of an intron, an exon, a coding sequence and a regulatory element.

18. The method according to claim 10 , wherein the DNA is contacted transiently by transiently introducing into the cell the first and second fusion proteins using an aqueous medium comprising the plant protoplasts, and wherein the medium further comprises:
2-80 nanomolar (nM) of the first and second fusion protein;
30-600 nanomolar (nM) of the guide RNA;
less than 0.1% (v/v) glycerol;
100-400 mg/ml PEG; and
10,000-2,000,000 plant protoplast cells/ml.

Assignees

• Keygene Nv

Inventors

• Bundock Paul

Classifications

• C12N2800/80

  Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title

• A01G2/30

  Grafting (grafting-wax  A01N3/04) · CPC title

• C12N9/22

  Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

• C12N15/11

  DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

• C12N9/78

  acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title